November 27, 2020
Seeking Alpha
SQZ is a biotechnology company that develops and commercializes cell therapies for the treatment of cancer and autoimmune diseases. Read more
SQZ’s Competitors, Revenue, Number of Employees, Funding, Acquisitions & News
31 Followers on Owler
31 Followers on Owler
SQZ is a biotechnology company that develops and commercializes cell therapies for the treatment of cancer and autoimmune diseases. Read more
Founder & CEO
Armon Sharei
Annual Revenue
Employees
Headquarters
Missing a competitor? Contribute!
CytomX is SQZ's #1 competitor. CytomX's headquarters is in South San Francisco, California, and was founded in 2008. Like SQZ, CytomX also works within the Biotechnology sector. CytomX generates 458% of SQZ's revenue.
Weigh-in!
Help the Owler community know moreTrending News for SQZ and SQZ's Competitors
November 27, 2020
BioSpace
Protalix BioTherapeutics and Chiesi Global Rare Diseases Announce Extension of PDUFA Date for Pegunigalsidase Alfa for the Proposed Treatment of Fabry Disease
Protalix BioTherapeutics, Inc. (NYSE American: PLX) (TASE: PLX), a biopharmaceutical company focused ... See more »
November 27, 2020
Seeking Alpha
FDA extends Protalix Bio's target action date for PRX-102 application to April 27, 2021
Quarterly and Annual Revenue
Trailing 12-Months Trend (TTM)
Annual Revenue
$20.1M
SQZ's revenue is the ranked 4th among it's top 10 competitors. The top 10 competitors average 17.2M. Over the last one quarters, SQZ's revenue has decreased by 0%. Specifically, in Q4 2019's revenue was $20.1M.
Acquisitions
No recent acquisitions found related to SQZ
SQZ Funding History
Since SQZ was founded in 2013, it has participated in 7 rounds of funding. In total SQZ has raised $258.5M. SQZ's last funding round was on Oct 2020 for a total of $91.3M
Investments
No recent investments found related to SQZ
SQZ News
November 3, 2020Global University Venturing
SQZ Bio squeezes on to NYSE - Global University Venturing
The MIT cell therapy spinout priced its shares at the bottom of their range to raise $70.6m, followin... See more »
October 30, 2020The Business Journals
Watertown biotech SQZ starts trading after $71M IPO
A decade ago, Armon Sharei stumbled across a simple method of getting things inside cells to create t... See more »
July 20, 2020Boston Citybizlist
SQZ Biotech Appoints Paul Bolno, MD to Board of Directors and Kai Wucherpfennig, MD, PhD to Scientific Advisory Board
May 21, 2020Forbes
Meet The MIT PhD Who Just Raised $65 Million For His Clinical Stage Cell Therapy Company
Armon Sharei's SQZ Biotech announced it raised a $65 Million-Series D round, led by Temasek with part... See more »
SQZ Press Releases
January 30, 2020GlobalNewswire
SQZ Biotech Announces First Patient Dosed in Phase 1 Trial of SQZ-PBMC-HPV for HPV+ Tumors
Trial is evaluating SQZ-PBMC-HPV as both monotherapy and in combination with a checkpoint inhibitor... See more »
October 22, 2019GlobalNewswire
SQZ Biotech Announces Clearance of US IND Application for First Clinical Trial
First program advancing into the clinic through the SQZ-Roche collaboration in APCs for oncologyFirst... See more »
September 17, 2019GlobalNewswire
SQZ Biotech Appoints Legal Life Sciences Expert, Lawrence Knopf, as General Counsel
WATERTOWN, Mass., Sept. 17, 2019 (GLOBE NEWSWIRE) -- SQZ Biotechnologies (SQZ), a cell therapy compan... See more »
May 29, 2019GlobeNewswire
SQZ Biotech Strengthens Board of Directors with Appointment of Leading Cell Therapy Expert and Biotech Veteran
Isaac Ciechanover, MD, MBA, to join board of directors as SQZ prepares to enter the clinic with its i... See more »
May 14, 2019GlobeNewswire
SQZ Biotech to Present at Investor Conferences in May & June
WATERTOWN, Mass., May 14, 2019 (GLOBE NEWSWIRE) -- SQZ Biotechnologies (SQZ), a cell therapy company ... See more »
April 25, 2019GlobeNewswire
SQZ Biotech to Present at the American Society of Gene and Cell Therapy (ASGCT) 22nd Annual Meeting
WATERTOWN, Mass., April 25, 2019 (GLOBE NEWSWIRE) -- SQZ Biotechnologies (SQZ), a cell therapy compan... See more »
March 28, 2019GlobeNewswire
SQZ Biotech to Present at the Jefferies Immuno-Oncology Cell Therapy Summit
WATERTOWN, Mass., March 28, 2019 (GLOBE NEWSWIRE) -- SQZ Biotechnologies (SQZ), a cell therapy compan... See more »
Social Media
Headquarters
Trending Companies
IN THE NEWS
Cadence | Lowe's | Optum | Alabama Power | Esteria79 | Global Blue | Avis Budget Group | HDFC | ASML | Discover | J.B. Hunt | MyoKardia | Orocobre | Visa | Rimba Raya | Middleby | Guidewire | MPS | Global Payments | Miro Forestry | Microsoft | United Rentals | Future Group | ICE | John Lewis | Capitan Mining | Mylan | Franco-Nevada | GIMEG | Sachem Capital | Paytm | Akcea Therapeutics | The GEO Group | KeyBank | SKS Business Services | Caesars Entertainment | Porsche | Xaar | Bank of Hawaii | Kimberly-Clark | Avient Distribution | Lightspeed Venture Partners | ICON | Mirae Asset | Blackberry | Tyler Technologies | McKibbon | Biogen | Paychex | Crown Castle
PEOPLE ALSO VIEWED
Lyngemark Satellite | Inquirly Technologies | Infometry | Ivan's Motor | ZION Industries | Delaware River Tubing | Kiddowear | Union Solutions | Dianne Medina | Opticwash | Solectek | The Horchow Collection | Pico Npwt | Expert Mining Solutions | McCracken Label | Sugarpine Woodcarving Supplies | Media.net | Klondike Kate's | Leap | Websplanet | Android Central | Locolist | Milbnk | Twisted Wardrobe Designs | Frigus BOHN SA de CV | Golden Beverage Company | The Plains Agency | Innoviant | ThermoEnergy | Mary's Little Lambs Preschool
Summary
ABOUT
Overview
SQZ is a biotechnology company that develops and commercializes cell therapies for the treatment of cancer and autoimmune diseases. SQZ was founded in 2013. SQZ's headquarters is located in Watertown, Massachusetts, USA 02472. It has raised 258.5M in ...
CEO
SQZ's Founder & CEO, Armon Sharei, currently has an approval rating of 88%. SQZ's primary competitors are CytomX, Cleveland BioLabs & Onconova.Website
sqzbiotech.comFrequently Asked Questions about SQZ
When was SQZ founded?
SQZ was founded in 2013Who is SQZ's CEO?
SQZ's CEO is Armon ShareiHow much revenue does SQZ generate?
SQZ generates $20.1M in revenueHow much funding does SQZ have?
SQZ has historically raised $258.5M in funding
Where is SQZ's headquarters?
SQZ's headquarters is in Watertown Massachusetts, USAHow many employees does SQZ have?
SQZ has 101 employeesWhat sector does SQZ operate in?
SQZ is in Biotechnology, PharmaceuticalsWho are SQZ's competitors?
SQZ's top competitors are CytomX, Cleveland BioLabs, Onconova
